Spatiotemporal Controllable Sono‐Nanovaccines Driven by Free‐Field Based Whole‐Body Ultrasound for Personalized Cancer Therapy
Advanced Science · 2024
DOI: 10.1002/advs.202307920 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Yang Wang und 18 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Fine Chemicals, School of Chemical Engineering, Dalian University of Technology, Dalian, 116024, China. Hauptthemen laut MEDLINE: Cancer Vaccines, Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Liaoning Xingliao Talent Plan Project, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Therapeutic cancer vaccines fail to produce satisfactory outcomes against solid tumors since vaccine‐induced anti‐tumor immunity is significantly hampered by immunosuppression. Generating an in situ cancer vaccine targeting immunological cold tumor microenvironment (TME) appears attractive. Here, a type of free‐field based whole‐body ultrasound (US)‐driven nanovaccines are constructed, named G5‐CHC‐R, by conjugating the sonosensitizer, Chenghai chlorin (CHC) and the immunomodulator, resiquimod (R848) on top of a super small‐sized dendrimeric nanoscaffold. Once entering tumors, R848 can be cleaved from a hypoxia‐sensitive linker, thus modifying the TME via converting macrophage phenotypes. The animals bearing orthotopic pancreatic cancer with intestinal metastasis and breast cancer with lung metastasis are treated with G5‐CHC‐R under a free‐field based whole‐body US system. Benefit from the deep penetration capacity and highly spatiotemporal selectiveness, G5‐CHC‐R triggered by US represented a superior alternative for noninvasive irradiation of deep‐seated tumors and magnification of local immune responses via driving mass release of tumor antigens and “cold‐warm‐hot” three‐state transformation of TME. In addition to irradiating primary tumors, a robust adaptive anti‐tumor immunity is potentiated, leading to successful induction of systemic tumor suppression. The sono‐nanovaccines with good biocompatibility posed wide applicability to a broad spectrum of tumors, revealing immeasurable potential for translational research in oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Fine Chemicals, School of Chemical Engineering, Dalian University of Technology, Dalian, 116024, China.
- State Key Laboratory of Fine Chemicals, Department of Pharmacy, School of Chemical Engineering, Dalian University of Technology, Dalian, 116024, China.
- Nuclear Medicine, First Affiliated Hospital of Dalian Medical University, Dalian, 116021, China.
- Department of Urology, First Affiliated Hospital of Dalian Medical University, Dalian, 116021, China.
ORCID-Profile: Guangzhe Li, Kun Shao
Förderung
- National Natural Science Foundation of China
- Liaoning Xingliao Talent Plan Project
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Wang, Y., Li, G., Su, J., Liu, Y., Zhang, X., Zhang, G., Wu, Z., Li, J., Zhang, Y., Wang, X., Yang, Z., Wang, R., Wang, C., Wang, L., Sun, F., Zhao, W., Wang, X., Peng, X., & Shao, K. (2024). Spatiotemporal Controllable Sono‐Nanovaccines Driven by Free‐Field Based Whole‐Body Ultrasound for Personalized Cancer Therapy. Advanced Science. https://doi.org/10.1002/advs.202307920
Vancouver
Wang Y, Li G, Su J, Liu Y, Zhang X, Zhang G, et al. Spatiotemporal Controllable Sono‐Nanovaccines Driven by Free‐Field Based Whole‐Body Ultrasound for Personalized Cancer Therapy. Advanced Science. 2024. doi:10.1002/advs.202307920
BibTeX
@article{Wang2024,
author = {Wang, Yang and Li, Guangzhe and Su, Jianlong and Liu, Yiming and Zhang, Xiaomai and Zhang, Guanyi and Wu, Zhihao and Li, Jinrong and Zhang, Yuxuan and Wang, Xu and Yang, Zejia and Wang, Ruimin and Wang, Chengdong and Wang, Liu and Sun, Fangfang and Zhao, Weijie and Wang, Xuejian and Peng, Xiaojun and Shao, Kun},
title = {Spatiotemporal Controllable Sono‐Nanovaccines Driven by Free‐Field Based Whole‐Body Ultrasound for Personalized Cancer Therapy},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202307920}
}
EUVIMED